Home Featured Page 278

Featured

Latest

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

Jean-Francois Sobiecki – African Psychoactive Plants & Phytoalchemy

March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

Vince Kadlubek – Meow Wolf & PORTAL

PT226 – Veronika Gold & Harvey Schwartz from Polaris Insight Center

PT229 – Dr. Matthew Johnson – What is Consciousness?

Light Years – Film Screening and Panel Discussion

PT230 – Penny White of NeonMind Biosciences

DMT for Depression: Paving the Way for New Medicine

Changa vs. DMT: What You Need to Know

Is the DMT Experience a Hallucination?

DMT Art: A Look Behind Visionary Creations

1...277278279...284 Page 278 of 284

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape...

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

Jean-Francois Sobiecki – African Psychoactive Plants & Phytoalchemy

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Featured

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape 2025 Landscape

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

Jean-Francois Sobiecki – African Psychoactive Plants & Phytoalchemy

March 2025’s Psychedelic Policy Momentum: New Bills Filed Across the U.S. as Nearly 30 States Deliberate Reforms

Vince Kadlubek – Meow Wolf & PORTAL

PT226 – Veronika Gold & Harvey Schwartz from Polaris Insight Center

PTSF 45

PT229 – Dr. Matthew Johnson – What is Consciousness?

Light Years – Film Screening and Panel Discussion

PT230 – Penny White of NeonMind Biosciences

DMT for Depression: Paving the Way for New Medicine

Changa vs. DMT: What You Need to Know

Is the DMT Experience a Hallucination?

Why Does DMT Pervade Nature?

DMT Art: A Look Behind Visionary Creations

EDITOR PICKS

Psychedelic Policy Update: Medical Access, Industry Influence, and Voter Suppression Shape...

BREAKING: New Mexico Passes Nation’s First Legislature-Driven Psilocybin Access Act

Jean-Francois Sobiecki – African Psychoactive Plants & Phytoalchemy

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY